Medical treatment codes for insomnia have been updated, with codes for treatment medication (MCT) and laboratory treatment codes (LT) for new medication.
The new code will be used for all new medication for people who have suffered from insomnia and are not currently taking any other medication.
It is also used to treat insomnia in people who are on certain medications.
The code will also be used to make certain diagnoses in cases where it is unclear whether a patient is suffering from a specific disease.
Dr Giorgio Bagnotti, the president of the European Medicines Agency, said the code was a “step forward” in tackling insomnia.
The codes were introduced last year, but the last time the codes were updated was in July this year, the EU Health Agency said.
The first version of the new code was introduced by the European Commission in 2018.
It was also launched by the French Health Minister and Minister of Health of the Republic of Lithuania.
Dr Bagnotto said the new codes are aimed at improving the lives of people who suffer from insomnia.
“In the last 10 years, there has been a huge increase in the number of people suffering from insomnia, with the rate of incidence increasing,” he said.
“It is a major challenge to provide the right medication for all of us, which is why we are introducing the codes.
This is a huge step forward and it is something that we hope will become more common throughout the world.”